메뉴 건너뛰기




Volumn 43, Issue 3, 1998, Pages 233-244

Serum lipid physiology and the influence of glaucoma medications

Author keywords

adrenergic blockers; Cholesterol; Coronary heart disease; Lipid; Ocular hypertension; Primary open angle glaucoma

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIGLAUCOMA AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; APOLIPOPROTEIN C2; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARTEOLOL; CHOLESTEROL; CHYLOMICRON; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN; ISOSORBIDE DINITRATE; LATANOPROST; LIPID; LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; PROPRANOLOL; PROSTAGLANDIN; TIMOLOL MALEATE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

EID: 0031768053     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(98)00030-7     Document Type: Review
Times cited : (15)

References (135)
  • 2
    • 0018191438 scopus 로고
    • 2+ precipitation procedures for estimating cholesterol in high-density lipoprotein
    • 2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin Chem. 24:1978;853-856.
    • (1978) Clin Chem , vol.24 , pp. 853-856
    • Albers, J.J.1    Warnick, G.R.2    Wiebe, D.3
  • 3
    • 0030022929 scopus 로고    scopus 로고
    • Clinical guideline, part 1. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults
    • The American College of Physicians
    • The American College of Physicians Clinical guideline, part 1. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med. 124:1996;515-517.
    • (1996) Ann Intern Med , vol.124 , pp. 515-517
  • 4
    • 0023121401 scopus 로고
    • Cholesterol and mortality. Thirty years of follow-up from the Framingham Study
    • Anderson K.M., Castelli W.P., Levy D. Cholesterol and mortality. Thirty years of follow-up from the Framingham Study. JAMA. 257:1987;2176-2180.
    • (1987) JAMA , vol.257 , pp. 2176-2180
    • Anderson, K.M.1    Castelli, W.P.2    Levy, D.3
  • 5
    • 0028939363 scopus 로고
    • The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
    • Anderson T.J., Meredith I.T., Yeung A.C.et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 332:1995;488-493.
    • (1995) N Engl J Med , vol.332 , pp. 488-493
    • Anderson, T.J.1    Meredith, I.T.2    Yeung, A.C.3
  • 6
    • 0023807047 scopus 로고
    • Low-density lipoprotein subclass patterns and risk of myocardial infarction
    • Austin M.A., Breslow J.L., Hennekens C.H.et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 260:1988;1917-1921.
    • (1988) JAMA , vol.260 , pp. 1917-1921
    • Austin, M.A.1    Breslow, J.L.2    Hennekens, C.H.3
  • 7
    • 0030587237 scopus 로고    scopus 로고
    • Lowering risk without lowering cholesterol. Implications for national cholesterol policy
    • Avins A.L., Browner W.S. Lowering risk without lowering cholesterol. Implications for national cholesterol policy. Ann Intern Med. 125:1996;502-506.
    • (1996) Ann Intern Med , vol.125 , pp. 502-506
    • Avins, A.L.1    Browner, W.S.2
  • 8
    • 0018107663 scopus 로고
    • Relation between prognosis and the blood pressure before and during treatment of hypertensive patients
    • Beevers D.G., Johnston J., Devine B.L.et al. Relation between prognosis and the blood pressure before and during treatment of hypertensive patients. Clin Sci Mol Med. 4(Suppl):1978;333S-336S.
    • (1978) Clin Sci Mol Med , vol.4 , Issue.SUPPL
    • Beevers, D.G.1    Johnston, J.2    Devine, B.L.3
  • 9
    • 0029808302 scopus 로고    scopus 로고
    • Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene
    • Benlian P., DeGenes J.L., Foubert L.et al. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med. 335:1996;848-854.
    • (1996) N Engl J Med , vol.335 , pp. 848-854
    • Benlian, P.1    Degenes, J.L.2    Foubert, L.3
  • 10
    • 0017947456 scopus 로고
    • Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia
    • Bilheimer D.W., Ho Y.K., Brown M.S.et al. Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia. J Clin Invest. 61:1978;678-696.
    • (1978) J Clin Invest , vol.61 , pp. 678-696
    • Bilheimer, D.W.1    Ho, Y.K.2    Brown, M.S.3
  • 11
    • 0026654987 scopus 로고
    • Prostaglandins suppress VLDL secretion in primary rat hepatocyte cultures. Relationships to hepatic calcium metabolism
    • Björnsson ÓG., Sparks J.D., Sparks C.E., Gibbons G.F. Prostaglandins suppress VLDL secretion in primary rat hepatocyte cultures. Relationships to hepatic calcium metabolism. J Lipid Res. 33:1992;1017-1027.
    • (1992) J Lipid Res , vol.33 , pp. 1017-1027
    • Björnsson, Ó.G.1    Sparks, J.D.2    Sparks, C.E.3    Gibbons, G.F.4
  • 12
    • 0027455653 scopus 로고
    • Dietary treatment and growth of hyperchylomicronemic children severely restricted in dietary fat
    • Black D.M., Sprecher D.L. Dietary treatment and growth of hyperchylomicronemic children severely restricted in dietary fat. Am J Dis Child. 147:1993;60-62.
    • (1993) Am J Dis Child , vol.147 , pp. 60-62
    • Black, D.M.1    Sprecher, D.L.2
  • 13
    • 0022549920 scopus 로고
    • A receptor-mediated pathway for cholesterol homeostatis
    • Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostatis. Science. 232:1986;34-47.
    • (1986) Science , vol.232 , pp. 34-47
    • Brown, M.S.1    Goldstein, J.L.2
  • 14
    • 0030888615 scopus 로고    scopus 로고
    • Hypercholesterolemia in the United States. How far have we come?
    • Brown W.V. Hypercholesterolemia in the United States. How far have we come? Am J Med. 102:1997;3-6.
    • (1997) Am J Med , vol.102 , pp. 3-6
    • Brown, W.V.1
  • 15
    • 0015783897 scopus 로고
    • Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man
    • Brunzell J.D., Hazzard W.R., Porte D., Bierman E.L. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest. 52:1973;1578-1585.
    • (1973) J Clin Invest , vol.52 , pp. 1578-1585
    • Brunzell, J.D.1    Hazzard, W.R.2    Porte, D.3    Bierman, E.L.4
  • 16
    • 0026609806 scopus 로고
    • Decreased HDL2 and HDL3 cholesterol, apoA-I, and apoA-II, and increased risk for myocardial infarction
    • Buring J.E., O'Connor G.T., Goldhaber S.Z.et al. Decreased HDL2 and HDL3 cholesterol, apoA-I, and apoA-II, and increased risk for myocardial infarction. Circulation. 85:1992;22-29.
    • (1992) Circulation , vol.85 , pp. 22-29
    • Buring, J.E.1    O'Connor, G.T.2    Goldhaber, S.Z.3
  • 17
    • 85047691979 scopus 로고
    • β-blockers, dyslipidemia, and coronary artery disease. A reassessment
    • Burris J.F. β-blockers, dyslipidemia, and coronary artery disease. A reassessment. Arch Intern Med. 153:1993;2085-2092.
    • (1993) Arch Intern Med , vol.153 , pp. 2085-2092
    • Burris, J.F.1
  • 18
    • 0028845911 scopus 로고
    • Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program
    • Byington R.P., Jukema J.W., Salonen J.T.et al. Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation. 92:1995;2419-2425.
    • (1995) Circulation , vol.92 , pp. 2419-2425
    • Byington, R.P.1    Jukema, J.W.2    Salonen, J.T.3
  • 19
    • 0023029454 scopus 로고
    • Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study
    • Castelli W.P., Garrisson R.J., Wilson P.W.F.et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 256:1986;2835-2838.
    • (1986) JAMA , vol.256 , pp. 2835-2838
    • Castelli, W.P.1    Garrisson, R.J.2    Wilson, P.W.F.3
  • 20
    • 0344084303 scopus 로고
    • Role of lipids in predicting CHD risk
    • Castelli W.P. Role of lipids in predicting CHD risk. Choices Cardiol. 7:1993;128-131.
    • (1993) Choices Cardiol , vol.7 , pp. 128-131
    • Castelli, W.P.1
  • 21
  • 22
    • 0026334459 scopus 로고
    • Intestinally-derived lipoproteins. Metabolism and clinical significance
    • Chen Y.D.I., Reaven G.M. Intestinally-derived lipoproteins. Metabolism and clinical significance. Diabetes Metab Rev. 7:1991;191-208.
    • (1991) Diabetes Metab Rev , vol.7 , pp. 191-208
    • Chen, Y.D.I.1    Reaven, G.M.2
  • 23
    • 0030960979 scopus 로고    scopus 로고
    • Adults aged 20 and older should have their cholesterol measured
    • Cleeman J.I. Adults aged 20 and older should have their cholesterol measured. Am J Med. 102:1997;31-36.
    • (1997) Am J Med , vol.102 , pp. 31-36
    • Cleeman, J.I.1
  • 24
    • 0022959261 scopus 로고
    • Prostaglandins and experimental hypertension. A review with special emphasis on the effect of dietary lipids
    • Codde J.P., Beilin L.J. Prostaglandins and experimental hypertension. A review with special emphasis on the effect of dietary lipids. J Hypertension. 4:1986;675-686.
    • (1986) J Hypertension , vol.4 , pp. 675-686
    • Codde, J.P.1    Beilin, L.J.2
  • 25
    • 0025124970 scopus 로고
    • Topical timolol decreases plasma high-density lipoprotein cholesterol level
    • Coleman A.L., Diehl D.L.C., Jampel H.D.et al. Topical timolol decreases plasma high-density lipoprotein cholesterol level. Arch Ophthalmol. 108:1990;1260-1263.
    • (1990) Arch Ophthalmol , vol.108 , pp. 1260-1263
    • Coleman, A.L.1    Diehl, D.L.C.2    Jampel, H.D.3
  • 26
    • 0023895495 scopus 로고
    • Use of an angiotensin-converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma
    • Constad W.H., Fiore P., Samson C., Cinotti A. Use of an angiotensin-converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma. Am J Ophthalmol. 105:1988;674-677.
    • (1988) Am J Ophthalmol , vol.105 , pp. 674-677
    • Constad, W.H.1    Fiore, P.2    Samson, C.3    Cinotti, A.4
  • 27
    • 0023091633 scopus 로고
    • Beta-blockers. Use for arrhythmias
    • Coumel P., Leclerq J.-F., Escoubet B. Beta-blockers. Use for arrhythmias. Eur Heart J. 8(Suppl A):1987;41-52.
    • (1987) Eur Heart J , vol.8 , Issue.SUPPL. A , pp. 41-52
    • Coumel, P.1    Leclerq, J.-F.2    Escoubet, B.3
  • 28
    • 0026736537 scopus 로고
    • The case for beta-blockers as first-line antihypertensive therapy
    • Cruickshank J.M. The case for beta-blockers as first-line antihypertensive therapy. J Hypertens. 10(Suppl 3):1992;S21-S27.
    • (1992) J Hypertens , vol.10 , Issue.SUPPL. 3
    • Cruickshank, J.M.1
  • 30
    • 0015922417 scopus 로고
    • Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy
    • Davidoff F., Tishler S., Rosoff C. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. N Engl J Med. 289:1973;552-555.
    • (1973) N Engl J Med , vol.289 , pp. 552-555
    • Davidoff, F.1    Tishler, S.2    Rosoff, C.3
  • 31
    • 0028157438 scopus 로고
    • Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia
    • Denke M.A., Grundy S.M. Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia. Arch Intern Med. 154:1994;317-325.
    • (1994) Arch Intern Med , vol.154 , pp. 317-325
    • Denke, M.A.1    Grundy, S.M.2
  • 32
    • 0029862973 scopus 로고    scopus 로고
    • Hyperinsulinemia as an independent risk factor for ischemic heart disease
    • Despres J.P., Lamarche B., Mauriege P.et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 334:1996;952-957.
    • (1996) N Engl J Med , vol.334 , pp. 952-957
    • Despres, J.P.1    Lamarche, B.2    Mauriege, P.3
  • 33
    • 0028196756 scopus 로고
    • The insulin resistance syndrome (syndrome X) and risk factors for coronary heart disease. An epidemiologic overview
    • Donahue R.P. The insulin resistance syndrome (syndrome X) and risk factors for coronary heart disease. An epidemiologic overview. Endocrinologist. 4:1994;112-116.
    • (1994) Endocrinologist , vol.4 , pp. 112-116
    • Donahue, R.P.1
  • 34
    • 0026702131 scopus 로고
    • Relation of level of high-density lipoprotein subfractions to the presence of extent of coronary artery disease
    • Drexel H., Amann F.W., Rentsch K.et al. Relation of level of high-density lipoprotein subfractions to the presence of extent of coronary artery disease. Am J Cardiol. 70:1992;436-440.
    • (1992) Am J Cardiol , vol.70 , pp. 436-440
    • Drexel, H.1    Amann, F.W.2    Rentsch, K.3
  • 35
    • 0344499774 scopus 로고
    • Hypertriglyceridemia. Pathophysiology, diagnosis, and treatment
    • Duell P.B. Hypertriglyceridemia. Pathophysiology, diagnosis, and treatment. Endocrinologist. 2:1992;321-331.
    • (1992) Endocrinologist , vol.2 , pp. 321-331
    • Duell, P.B.1
  • 36
    • 0024500560 scopus 로고
    • Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases
    • Eckel R.H. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med. 320:1989;1060-1068.
    • (1989) N Engl J Med , vol.320 , pp. 1060-1068
    • Eckel, R.H.1
  • 37
    • 0023930868 scopus 로고
    • Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults
    • The Expert Panel of the National Cholesterol Education Program
    • The Expert Panel of the National Cholesterol Education Program: Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 148:36-69, 1988.
    • (1988) Arch Intern Med , vol.148 , pp. 36-69
  • 38
    • 0027243348 scopus 로고
    • Summary of the second report on the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
    • The Expert Panel on Detection, Evaluation, and Treatment of High Blood cholesterol in Adults
    • The Expert Panel on Detection, Evaluation, and Treatment of High Blood cholesterol in Adults: Summary of the second report on the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 269:3015-3023, 1993.
    • (1993) JAMA , vol.269 , pp. 3015-3023
  • 39
    • 0025780331 scopus 로고
    • Hyperinsulinemia. The key feature of a cardiovascular and metabolic syndrome
    • Ferrannini E., Haffner S.M., Mitchell B.D., Stern M.P. Hyperinsulinemia. The key feature of a cardiovascular and metabolic syndrome. Diabetologia. 34:1991;416-422.
    • (1991) Diabetologia , vol.34 , pp. 416-422
    • Ferrannini, E.1    Haffner, S.M.2    Mitchell, B.D.3    Stern, M.P.4
  • 40
    • 0025907493 scopus 로고
    • Antihypertensive agents, serum lipoproteins, and glucose metabolism
    • Ferrari P., Rosman J., Weidmann P. Antihypertensive agents, serum lipoproteins, and glucose metabolism. Am J Cardiol. 67:1991;26B-35B.
    • (1991) Am J Cardiol , vol.67
    • Ferrari, P.1    Rosman, J.2    Weidmann, P.3
  • 41
    • 0027525254 scopus 로고
    • Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level
    • Freedman S.F., Freedman N.J., Shields M.B.et al. Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level. Am J Ophthalmol. 116:1993;600-611.
    • (1993) Am J Ophthalmol , vol.116 , pp. 600-611
    • Freedman, S.F.1    Freedman, N.J.2    Shields, M.B.3
  • 42
    • 0023232216 scopus 로고
    • Helsinki Heart Study. Primary prevention trial of gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
    • Frick M.H., Elo O., Haapa K.et al. Helsinki Heart Study. Primary prevention trial of gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 317:1987;1237-1245.
    • (1987) N Engl J Med , vol.317 , pp. 1237-1245
    • Frick, M.H.1    Elo, O.2    Haapa, K.3
  • 43
    • 0028134712 scopus 로고
    • Topical ophthalmic β-adrenergic blockade for the treatment of glaucoma and ocular hypertension
    • Frishman W.H., Fuksbrumer M.S., Tannenbaum M. Topical ophthalmic β-adrenergic blockade for the treatment of glaucoma and ocular hypertension. J Clin Pharmacol. 34:1994;795-803.
    • (1994) J Clin Pharmacol , vol.34 , pp. 795-803
    • Frishman, W.H.1    Fuksbrumer, M.S.2    Tannenbaum, M.3
  • 44
    • 0030049396 scopus 로고    scopus 로고
    • Cholesterol screening in asymptomatic adults, revisited, part 2
    • Garber A.M., Browner W.S., Hulley S.B. Cholesterol screening in asymptomatic adults, revisited, part 2. Ann Intern Med. 124:1996;518-531.
    • (1996) Ann Intern Med , vol.124 , pp. 518-531
    • Garber, A.M.1    Browner, W.S.2    Hulley, S.B.3
  • 45
    • 0028126081 scopus 로고
    • Lipoprotein metabolism and its relationship to atherosclerosis
    • Ginsberg H.N. Lipoprotein metabolism and its relationship to atherosclerosis. Med Clin North Am. 78:1994;1-20.
    • (1994) Med Clin North Am , vol.78 , pp. 1-20
    • Ginsberg, H.N.1
  • 46
    • 0015839023 scopus 로고
    • Hyperlipidemia and coronary artery disease. I. Lipid levels in 500 survivors of myocardial infarction
    • Goldstein J.L., Hazzard W.R., Schrott H.et al. Hyperlipidemia and coronary artery disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest. 52:1973;1533-1543.
    • (1973) J Clin Invest , vol.52 , pp. 1533-1543
    • Goldstein, J.L.1    Hazzard, W.R.2    Schrott, H.3
  • 47
    • 0015796295 scopus 로고
    • Hyperlipidemia in coronary artery disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
    • Goldstein J.L., Schrott H., Hazzard W.R.et al. Hyperlipidemia in coronary artery disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 52:1973;1544-1568.
    • (1973) J Clin Invest , vol.52 , pp. 1544-1568
    • Goldstein, J.L.1    Schrott, H.2    Hazzard, W.R.3
  • 48
    • 0024449985 scopus 로고
    • High-density lipoprotein. The clinical implications of recent studies
    • Gordon D.J., Rifkind B.M. High-density lipoprotein. The clinical implications of recent studies. N Engl J Med. 321:1989;1311-1316.
    • (1989) N Engl J Med , vol.321 , pp. 1311-1316
    • Gordon, D.J.1    Rifkind, B.M.2
  • 49
    • 0026344120 scopus 로고
    • Heterogenous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency
    • Gotoda T., Yamada N., Kawamura M.et al. Heterogenous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency. J Clin Invest. 88:1991;1856-1864.
    • (1991) J Clin Invest , vol.88 , pp. 1856-1864
    • Gotoda, T.1    Yamada, N.2    Kawamura, M.3
  • 51
    • 0026062564 scopus 로고
    • Workshop II - Hypertension trials and meta-analyses. Is there any value for further studies?
    • Grimm R.H., Black H. Workshop II - hypertension trials and meta-analyses. Is there any value for further studies? Am J Med. 90(Suppl 2A):1991;S24-S25.
    • (1991) Am J Med , vol.90 , Issue.SUPPL. 2A
    • Grimm, R.H.1    Black, H.2
  • 52
    • 0026586191 scopus 로고
    • Two different views of the relationship of hypertriglyceridemia to coronary heart disease
    • Grundy S.M., Vega G.L. Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Arch Intern Med. 152:1992;28-34.
    • (1992) Arch Intern Med , vol.152 , pp. 28-34
    • Grundy, S.M.1    Vega, G.L.2
  • 53
    • 0028569584 scopus 로고
    • Choosing the right β-blocker. A guide to selection
    • Hampton J.R. Choosing the right β-blocker. A guide to selection. Drugs. 48:1994;549-568.
    • (1994) Drugs , vol.48 , pp. 549-568
    • Hampton, J.R.1
  • 54
    • 0027489806 scopus 로고
    • The place of β-blockers in the treatment of hypertension in 1993
    • Hansson L. The place of β-blockers in the treatment of hypertension in 1993. Clin Exp Hyperten. 15:1993;1257-1262.
    • (1993) Clin Exp Hyperten , vol.15 , pp. 1257-1262
    • Hansson, L.1
  • 55
    • 0027359490 scopus 로고
    • How well are the cardiovascular risk profiles modulated by current beta blockers in hypertension?
    • Hayduk K. How well are the cardiovascular risk profiles modulated by current beta blockers in hypertension? Cardiology. 82(Suppl 3):1993;3-7.
    • (1993) Cardiology , vol.82 , Issue.SUPPL. 3 , pp. 3-7
    • Hayduk, K.1
  • 56
    • 0015892771 scopus 로고
    • Hyperlipidemia in coronary artery disease
    • Hazzard W.R., Goldstein J.L., Schrott H.et al. Hyperlipidemia in coronary artery disease. III. Evaluation of lipoprotein phenotypes of. 156(genetically defined survivors of myocardial infarction. J Clin Invest 52):1973;1569-1577.
    • (1973) III. Evaluation of Lipoprotein Phenotypes of , vol.156 , Issue.GENETICALLY DEFINED SURVIVORS OF MYOCARDIAL INFARCTION. J CLIN INVEST 52 , pp. 1569-1577
    • Hazzard, W.R.1    Goldstein, J.L.2    Schrott, H.3
  • 58
    • 0025102741 scopus 로고
    • Familial defective apolipoprotein B-100: A mutation of apolipoprotein B that causes hypercholesterolemia
    • Innerarity T.L., Mahley R.W., Weisgraber K.H.et al. Familial defective apolipoprotein B-100. a mutation of apolipoprotein B that causes hypercholesterolemia J Lipid Res. 31:1990;1337-1349.
    • (1990) J Lipid Res , vol.31 , pp. 1337-1349
    • Innerarity, T.L.1    Mahley, R.W.2    Weisgraber, K.H.3
  • 59
    • 0030066167 scopus 로고    scopus 로고
    • Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms
    • Innerarity T.L., Boren J., Yamanaka S., Olofsson S.-O. Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms. J Biol Chem. 271:1996;2353-2356.
    • (1996) J Biol Chem , vol.271 , pp. 2353-2356
    • Innerarity, T.L.1    Boren, J.2    Yamanaka, S.3    Olofsson, S.-O.4
  • 60
    • 0028032971 scopus 로고
    • Efficacy and safety of once-daily vs. twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia
    • Insull W. Jr., Black D., Dujovne C.et al. Efficacy and safety of once-daily vs. twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia. Arch Intern Med. 154:1994;2449-2455.
    • (1994) Arch Intern Med , vol.154 , pp. 2449-2455
    • Insull W., Jr.1    Black, D.2    Dujovne, C.3
  • 61
    • 0028067987 scopus 로고
    • The ACE inhibitor alacepril suppresses atherogenesis independent of serum lipids in cholesterol-fed rabbits. Critical analysis with new ultrasound technique
    • Itoh K., Yoshida S., Fukuda M. The ACE inhibitor alacepril suppresses atherogenesis independent of serum lipids in cholesterol-fed rabbits. Critical analysis with new ultrasound technique. Jpn Circ J. 58:1994;844-854.
    • (1994) Jpn Circ J , vol.58 , pp. 844-854
    • Itoh, K.1    Yoshida, S.2    Fukuda, M.3
  • 62
    • 1842404801 scopus 로고    scopus 로고
    • Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease
    • for the Scandinavian Simvastatin Survival Study
    • Johannesson M., Jonsson B., Kjekshus J.et al., for the Scandinavian Simvastatin Survival Study Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. N Engl J Med. 336:1997;332-336.
    • (1997) N Engl J Med , vol.336 , pp. 332-336
    • Johannesson, M.1    Jonsson, B.2    Kjekshus, J.3
  • 63
    • 0020062176 scopus 로고
    • The emerging problem of plasma lipid changes during antihypertensive therapy
    • Johnson B.F. The emerging problem of plasma lipid changes during antihypertensive therapy. J Cardiovasc Pharmacol. 4(Suppl 2):1982;S213-S221.
    • (1982) J Cardiovasc Pharmacol , vol.4 , Issue.SUPPL. 2
    • Johnson, B.F.1
  • 64
    • 0025900794 scopus 로고
    • Lecithin-cholesterol acyltransferase in metabolism of high-density lipoproteins
    • Jonas A. Lecithin-cholesterol acyltransferase in metabolism of high-density lipoproteins. Biochim Biophys Acta. 1084:1991;205-220.
    • (1991) Biochim Biophys Acta , vol.1084 , pp. 205-220
    • Jonas, A.1
  • 65
    • 0025685469 scopus 로고
    • Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens
    • Kane J.P., Malloy M.J., Ports T.A.et al. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA. 264:1990;3007-3012.
    • (1990) JAMA , vol.264 , pp. 3007-3012
    • Kane, J.P.1    Malloy, M.J.2    Ports, T.A.3
  • 66
    • 0018412417 scopus 로고
    • Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham Study
    • Kannel W.B., Castelli W.P., Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham Study. Ann Intern Med. 90:1979;85-91.
    • (1979) Ann Intern Med , vol.90 , pp. 85-91
    • Kannel, W.B.1    Castelli, W.P.2    Gordon, T.3
  • 67
    • 0027310351 scopus 로고
    • Multicenter double-blind comparison of carteolol and timolol in primary open-angle glaucoma and ocular hypertension
    • Kitazawa Y. Multicenter double-blind comparison of carteolol and timolol in primary open-angle glaucoma and ocular hypertension. Adv Ther. 10:1993;95-131.
    • (1993) Adv Ther , vol.10 , pp. 95-131
    • Kitazawa, Y.1
  • 68
    • 0030278155 scopus 로고    scopus 로고
    • Cholesterol-lowering and coronary atherosclerosis. Good news and bad news
    • Kreisberg R.A. Cholesterol-lowering and coronary atherosclerosis. Good news and bad news. Am J Med. 101:1996;455-458.
    • (1996) Am J Med , vol.101 , pp. 455-458
    • Kreisberg, R.A.1
  • 69
    • 0027396927 scopus 로고
    • Low high-density lipoprotein cholesterol. What does it mean, what can we do about it, and what should we do about it?
    • Kreisberg R.A. Low high-density lipoprotein cholesterol. What does it mean, what can we do about it, and what should we do about it? Am J Med. 94:1993;1-6.
    • (1993) Am J Med , vol.94 , pp. 1-6
    • Kreisberg, R.A.1
  • 70
    • 0028866519 scopus 로고
    • Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction
    • Lacoste L., Lam J.Y.T., Hung J.et al. Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction. Circulation. 92:1995;3172-3177.
    • (1995) Circulation , vol.92 , pp. 3172-3177
    • Lacoste, L.1    Lam, J.Y.T.2    Hung, J.3
  • 71
    • 0030027548 scopus 로고    scopus 로고
    • Cholesterol agonistics
    • LaRosa J.C. Cholesterol agonistics. Ann Intern Med. 124:1996;505-508.
    • (1996) Ann Intern Med , vol.124 , pp. 505-508
    • Larosa, J.C.1
  • 72
    • 0022569218 scopus 로고
    • A new challenge for America. The National Cholesterol Education Program
    • Lenfant C. A new challenge for America. The National Cholesterol Education Program. Circulation. 73:1986;855-856.
    • (1986) Circulation , vol.73 , pp. 855-856
    • Lenfant, C.1
  • 73
    • 0021288690 scopus 로고
    • Effect of alpha- And beta-blocker therapy on blood lipids. European experience
    • Leren P. Effect of alpha- and beta-blocker therapy on blood lipids. European experience. Am J Med. 75:1984;67-71.
    • (1984) Am J Med , vol.75 , pp. 67-71
    • Leren, P.1
  • 74
    • 0027430962 scopus 로고
    • Ischaemic heart disease. How well are the risk profiles modulated by current beta blockers?
    • Leren P. Ischaemic heart disease. How well are the risk profiles modulated by current beta blockers? Cardiology. 82(Suppl 3):1993;8-12.
    • (1993) Cardiology , vol.82 , Issue.SUPPL. 3 , pp. 8-12
    • Leren, P.1
  • 75
    • 0029650740 scopus 로고
    • Cholesterol reduction and cardiovascular disease. Clinical benefits and possible mechanisms
    • Levine G.N., Keaney J.F. Jr., Vita J.A. Cholesterol reduction and cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med. 332:1995;512-521.
    • (1995) N Engl J Med , vol.332 , pp. 512-521
    • Levine, G.N.1    Keaney J.F., Jr.2    Vita, J.A.3
  • 76
    • 0019080054 scopus 로고
    • The structure, function and metabolism of high-density lipoproteins. A status report
    • Levy R.I., Rifkind B.M. The structure, function and metabolism of high-density lipoproteins. A status report. Circulation. 62(Suppl IV):1980;4-8.
    • (1980) Circulation , vol.62 , Issue.SUPPL. IV , pp. 4-8
    • Levy, R.I.1    Rifkind, B.M.2
  • 77
    • 0027974105 scopus 로고
    • Long-term metabolic effects of antihypertensive drugs
    • Lind L., Pollare T., Berne C., Lithell H. Long-term metabolic effects of antihypertensive drugs. Am Heart J. 128:1994;1177-1183.
    • (1994) Am Heart J , vol.128 , pp. 1177-1183
    • Lind, L.1    Pollare, T.2    Berne, C.3    Lithell, H.4
  • 78
    • 0025870053 scopus 로고
    • Angiographic evolution of coronary atherosclerosis in patients receiving propranolol
    • Loaldi A., Montorsi P., Fabbiocchi F.et al. Angiographic evolution of coronary atherosclerosis in patients receiving propranolol. Chest. 99:1991;1238-1242.
    • (1991) Chest , vol.99 , pp. 1238-1242
    • Loaldi, A.1    Montorsi, P.2    Fabbiocchi, F.3
  • 79
    • 0025966833 scopus 로고
    • Effects of adrenaline and noradrenaline on clearance of triacylglycerol-rich lipoproteins from plasma: Studies with chylomicron-like lipid emulsions in rats
    • Mackintosh V., Redgrave T. Effects of adrenaline and noradrenaline on clearance of triacylglycerol-rich lipoproteins from plasma. studies with chylomicron-like lipid emulsions in rats Clin Exp Pharmacol Physiol. 18:1991;137-143.
    • (1991) Clin Exp Pharmacol Physiol , vol.18 , pp. 137-143
    • Mackintosh, V.1    Redgrave, T.2
  • 80
    • 0023726344 scopus 로고
    • Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study
    • Mannienen V., Elo O., Frick M.H.et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA. 260:1988;641-651.
    • (1988) JAMA , vol.260 , pp. 641-651
    • Mannienen, V.1    Elo, O.2    Frick, M.H.3
  • 81
    • 0030176054 scopus 로고    scopus 로고
    • Inadequate treatment with HMG-CoA reductase inhibitors by health care providers
    • Marcelino J.J., Feingold K.R. Inadequate treatment with HMG-CoA reductase inhibitors by health care providers. Am J Med. 100:1996;605-610.
    • (1996) Am J Med , vol.100 , pp. 605-610
    • Marcelino, J.J.1    Feingold, K.R.2
  • 82
    • 0022980592 scopus 로고
    • Serum cholesterol, blood pressure, and mortality
    • Martin M.J., Hulley S.B., Browner W.S.et al. Serum cholesterol, blood pressure, and mortality. Implications from a cohort of. 361,662(men. Lancet 2):1986;933-936.
    • (1986) Implications from a Cohort of , vol.361-662 , Issue.MEN. LANCET 2 , pp. 933-936
    • Martin, M.J.1    Hulley, S.B.2    Browner, W.S.3
  • 83
    • 0021863832 scopus 로고
    • MRC trial of treatment of mild hypertension: Principal results
    • Medical Research Council Working Party MRC trial of treatment of mild hypertension. principal results BMJ. 291:1985;97-104.
    • (1985) BMJ , vol.291 , pp. 97-104
    • Medical Research Council Working Party1
  • 84
    • 0026669282 scopus 로고
    • Long-term predictors of subsequent cardiovascular events with coronary artery disease and "desirable" levels of plasma total cholesterol
    • Miller M., Seidler A., Kwiterovich P.O., Pearson T.A. Long-term predictors of subsequent cardiovascular events with coronary artery disease and "desirable" levels of plasma total cholesterol. Circulation. 86:1992;1165-1170.
    • (1992) Circulation , vol.86 , pp. 1165-1170
    • Miller, M.1    Seidler, A.2    Kwiterovich, P.O.3    Pearson, T.A.4
  • 85
    • 0029152834 scopus 로고
    • New methods for rapid detection of low-density lipoprotein receptor and apolipoprotein B gene mutations causing familial hypercholesterolemia
    • Minnich A., Roy M., Chamberland A.et al. New methods for rapid detection of low-density lipoprotein receptor and apolipoprotein B gene mutations causing familial hypercholesterolemia. Clin Biochem. 28:1995;277-284.
    • (1995) Clin Biochem , vol.28 , pp. 277-284
    • Minnich, A.1    Roy, M.2    Chamberland, A.3
  • 86
    • 0018718026 scopus 로고
    • A longitudinal study of the biological variability of plasma lipoproteins in healthy young adults
    • Mjøs O.D., Rao S.N., Bjøru L.et al. A longitudinal study of the biological variability of plasma lipoproteins in healthy young adults. Atherosclerosis. 34:1979;75-81.
    • (1979) Atherosclerosis , vol.34 , pp. 75-81
    • Mjøs, O.D.1    Rao, S.N.2    Bjøru, L.3
  • 87
    • 0026681128 scopus 로고
    • Serum cholesterol and mortality findings for men screened in the Multiple Risk Factor Intervention Trial
    • Neaton J.D., Blackburn H., Jacobs D.et al. Serum cholesterol and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med. 152:1992;1490-1500.
    • (1992) Arch Intern Med , vol.152 , pp. 1490-1500
    • Neaton, J.D.1    Blackburn, H.2    Jacobs, D.3
  • 88
    • 0026593243 scopus 로고
    • Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men
    • for the Multiple Risk Factor Intervention Trial Research Group
    • Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group: Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Arch Intern Med 152:56-64, 1992.
    • (1992) Arch Intern Med , vol.152 , pp. 56-64
    • Neaton, J.D.1    Wentworth, D.2
  • 89
    • 0027175545 scopus 로고
    • Calcium channel blockers in the management of low-tension and open-angle glaucoma
    • Netland P.A., Chaturvedi N., Dreyer E.B. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol. 115:1993;608-613.
    • (1993) Am J Ophthalmol , vol.115 , pp. 608-613
    • Netland, P.A.1    Chaturvedi, N.2    Dreyer, E.B.3
  • 90
    • 0002533264 scopus 로고
    • Receptor mechanisms for epinephrine and timolol
    • E. Lutjen-Drecoll. Stuttgart: Germany, Schattauer
    • Neufeld A.H., Bartels S.P. Receptor mechanisms for epinephrine and timolol. Lutjen-Drecoll E. Basic Aspects of Glaucoma Research. 1982;113-122 Germany, Schattauer, Stuttgart.
    • (1982) Basic Aspects of Glaucoma Research , pp. 113-122
    • Neufeld, A.H.1    Bartels, S.P.2
  • 91
    • 0026573169 scopus 로고
    • Serum cholesterol profiles during treatment of obese outpatients with a very low calorie diet. Effect of initial cholesterol levels
    • Osterman J., Lin T., Nankin H.R.et al. Serum cholesterol profiles during treatment of obese outpatients with a very low calorie diet. Effect of initial cholesterol levels. Int J Obesity. 16:1992;49-58.
    • (1992) Int J Obesity , vol.16 , pp. 49-58
    • Osterman, J.1    Lin, T.2    Nankin, H.R.3
  • 92
    • 0030932585 scopus 로고    scopus 로고
    • Nonlipoprotein risk factors for coronary heart disease. Evaluation and management
    • Parmley W.W. Nonlipoprotein risk factors for coronary heart disease. Evaluation and management. Am J Med. 102(Suppl 2A):1997;7-14.
    • (1997) Am J Med , vol.102 , Issue.SUPPL. 2A , pp. 7-14
    • Parmley, W.W.1
  • 93
    • 0025633918 scopus 로고
    • Effect of calcium channel blockers on intraocular pressure
    • Payne L.J., Slagle T.M., Cheeks L.T., Green K. Effect of calcium channel blockers on intraocular pressure. Ophthalmic Res. 22:1990;337-341.
    • (1990) Ophthalmic Res , vol.22 , pp. 337-341
    • Payne, L.J.1    Slagle, T.M.2    Cheeks, L.T.3    Green, K.4
  • 94
    • 10244249180 scopus 로고    scopus 로고
    • Safety and tolerability of cholesterol lowering with simvastatin during five years in the Scandinavian Simvastatin Survival Study
    • Pedersen T.R., Berg K., Cook T.J.et al. Safety and tolerability of cholesterol lowering with simvastatin during five years in the Scandinavian Simvastatin Survival Study. Arch Intern Med. 156:1996;2085-2092.
    • (1996) Arch Intern Med , vol.156 , pp. 2085-2092
    • Pedersen, T.R.1    Berg, K.2    Cook, T.J.3
  • 95
    • 0029883280 scopus 로고    scopus 로고
    • Cholesterol lowering and the use of health care resources. Results of the Scandinavian Simvastatin Survival Study
    • Pedersen T.R., Kjekshus J., Berg K.et al. Cholesterol lowering and the use of health care resources. Results of the Scandinavian Simvastatin Survival Study. Circulation. 93:1996;1796-1802.
    • (1996) Circulation , vol.93 , pp. 1796-1802
    • Pedersen, T.R.1    Kjekshus, J.2    Berg, K.3
  • 96
    • 0028069487 scopus 로고
    • In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport
    • Pieters M.N., Schouten D., Van Berkel T.J.C. In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport. Biochim Biophys Acta. 1225:1994;125-134.
    • (1994) Biochim Biophys Acta , vol.1225 , pp. 125-134
    • Pieters, M.N.1    Schouten, D.2    Van Berkel, T.J.C.3
  • 97
    • 0027731239 scopus 로고
    • Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs
    • Rajman I., Kendall M.J. Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs. Postgrad Med J. 69:1993;903-911.
    • (1993) Postgrad Med J , vol.69 , pp. 903-911
    • Rajman, I.1    Kendall, M.J.2
  • 98
    • 0027183606 scopus 로고
    • Insulin resistance and hyperinsulinemia in individuals with small, dense low-density lipoprotein particles
    • Reaven G.M., Chen Y.D.I., Jeppesen J.et al. Insulin resistance and hyperinsulinemia in individuals with small, dense low-density lipoprotein particles. J Clin Invest. 92:1993;141-146.
    • (1993) J Clin Invest , vol.92 , pp. 141-146
    • Reaven, G.M.1    Chen, Y.D.I.2    Jeppesen, J.3
  • 99
    • 0029946120 scopus 로고    scopus 로고
    • Insulin resistance, its consequences, and coronary heart disease. Must we choose one culprit?
    • Reaven G.M., Chen Y.D.I. Insulin resistance, its consequences, and coronary heart disease. Must we choose one culprit? Circulation. 93:1996;1780-1783.
    • (1996) Circulation , vol.93 , pp. 1780-1783
    • Reaven, G.M.1    Chen, Y.D.I.2
  • 100
    • 0024388998 scopus 로고
    • Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism
    • Reichl D., Miller N.E. Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis. 9:1989;785-797.
    • (1989) Arteriosclerosis , vol.9 , pp. 785-797
    • Reichl, D.1    Miller, N.E.2
  • 101
    • 0028265434 scopus 로고
    • The ineffectiveness of a commonly recommended lipid-lowering diet in significantly lowering the serum total and low-density lipoprotein cholesterol levels
    • Roberts W.C. The ineffectiveness of a commonly recommended lipid-lowering diet in significantly lowering the serum total and low-density lipoprotein cholesterol levels. Am J Cardiol. 73:1994;623-624.
    • (1994) Am J Cardiol , vol.73 , pp. 623-624
    • Roberts, W.C.1
  • 102
    • 0027733783 scopus 로고
    • Effects of captopril on sympathetic activity, lipid and carbohydrate metabolism in a model of obesity-induced hypertension in dogs
    • Robles R.G., Villa E., Santirso R.et al. Effects of captopril on sympathetic activity, lipid and carbohydrate metabolism in a model of obesity-induced hypertension in dogs. Am J Hypertens. 6:1993;1009-1015.
    • (1993) Am J Hypertens , vol.6 , pp. 1009-1015
    • Robles, R.G.1    Villa, E.2    Santirso, R.3
  • 103
    • 0342981862 scopus 로고    scopus 로고
    • The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
    • Sacks F.M., Pfeffer M.A., Moye L.A.et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 335:1996;1001-1009.
    • (1996) N Engl J Med , vol.335 , pp. 1001-1009
    • Sacks, F.M.1    Pfeffer, M.A.2    Moye, L.A.3
  • 104
    • 0026657142 scopus 로고
    • Angiotensin-converting enzyme inhibition attenuates hypercholesterolemia and glomerular injury in hyperlipidemic Imai rats
    • Sakemi T., Baba N., Yoshikawa Y. Angiotensin-converting enzyme inhibition attenuates hypercholesterolemia and glomerular injury in hyperlipidemic Imai rats. Nephron. 62:1992;315-321.
    • (1992) Nephron , vol.62 , pp. 315-321
    • Sakemi, T.1    Baba, N.2    Yoshikawa, Y.3
  • 105
    • 0025974363 scopus 로고
    • The familial hyperchylomicronemia syndrome. New insights into underlying genetic defects
    • Santamarina-Fojo S., Brewer H.B. Jr. The familial hyperchylomicronemia syndrome. New insights into underlying genetic defects. JAMA. 265:1991;904-908.
    • (1991) JAMA , vol.265 , pp. 904-908
    • Santamarina-Fojo, S.1    Brewer H.B., Jr.2
  • 106
    • 0027987849 scopus 로고
    • Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study (4S)
    • The Scandinavian Simvastatin Survival Group Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study (. 4S).(Lancet 344):1994;1383-1389.
    • (1994) Lancet , vol.344 , pp. 1383-1389
    • The Scandinavian Simvastatin Survival Group1
  • 107
    • 0028316960 scopus 로고
    • Lipoprotein(a) levels and risk of coronary heart disease in men. The Lipid Research Clinics Coronary Primary Prevention Trial
    • Schaefer E.J., Lamon-Fava S., Jenner J.L.et al. Lipoprotein(a) levels and risk of coronary heart disease in men. The Lipid Research Clinics Coronary Primary Prevention Trial. JAMA. 271:1994;999-1003.
    • (1994) JAMA , vol.271 , pp. 999-1003
    • Schaefer, E.J.1    Lamon-Fava, S.2    Jenner, J.L.3
  • 108
    • 0028828560 scopus 로고
    • Body weight and low-density lipoprotein cholesterol changes after consumption of a low-fat ad libitum diet
    • Schaefer E.J., Lichtenstein A.H., Lamon-Fava S.et al. Body weight and low-density lipoprotein cholesterol changes after consumption of a low-fat ad libitum diet. JAMA. 274:1995;1450-1455.
    • (1995) JAMA , vol.274 , pp. 1450-1455
    • Schaefer, E.J.1    Lichtenstein, A.H.2    Lamon-Fava, S.3
  • 109
    • 0028011096 scopus 로고
    • Familial lipoprotein disorders and premature coronary artery disease
    • Schaefer E.J. Familial lipoprotein disorders and premature coronary artery disease. Med Clin North Am. 78:1994;21-39.
    • (1994) Med Clin North Am , vol.78 , pp. 21-39
    • Schaefer, E.J.1
  • 110
    • 0027724204 scopus 로고
    • Metabolic effects of converting enzyme inhibitors. Focus on the reduction of cholesterol and lipoprotein(a) by fosinopril
    • Schlueter W., Keilani T., Batlle D.C. Metabolic effects of converting enzyme inhibitors. Focus on the reduction of cholesterol and lipoprotein(a) by fosinopril. Am J Cardiol. 72:1993;37H-44H.
    • (1993) Am J Cardiol , vol.72
    • Schlueter, W.1    Keilani, T.2    Batlle, D.C.3
  • 111
    • 0019945144 scopus 로고
    • Central role of high density lipoprotein in plasma free cholesterol metabolism
    • Schwartz C.C., Vlahcevic Z.R., Berman M.et al. Central role of high density lipoprotein in plasma free cholesterol metabolism. J Clin Invest. 70:1982;105-116.
    • (1982) J Clin Invest , vol.70 , pp. 105-116
    • Schwartz, C.C.1    Vlahcevic, Z.R.2    Berman, M.3
  • 112
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
    • Shepherd J., Cobbe S.M., Ford J.et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 333:1995;1301-1307.
    • (1995) N Engl J Med , vol.333 , pp. 1301-1307
    • Shepherd, J.1    Cobbe, S.M.2    Ford, J.3
  • 115
    • 0027164257 scopus 로고
    • Comparison of the efficacy, safety, and tolerability of simvastatin and pravastatin for hypercholesterolemia
    • The Simvastatin Pravastatin Study Group Comparison of the efficacy, safety, and tolerability of simvastatin and pravastatin for hypercholesterolemia. Am J Cardiol. 71:1993;1408-1414.
    • (1993) Am J Cardiol , vol.71 , pp. 1408-1414
    • The Simvastatin Pravastatin Study Group1
  • 116
    • 0019454574 scopus 로고
    • Beta-adrenergic blockade after myocardial infarction
    • Sleight P. Beta-adrenergic blockade after myocardial infarction. N Engl J Med. 304:1981;837-838.
    • (1981) N Engl J Med , vol.304 , pp. 837-838
    • Sleight, P.1
  • 117
    • 0001434733 scopus 로고
    • Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)
    • for the MRFIT Research Group
    • Stamler J, Wentworth D, Neaton J, for the MRFIT Research Group: Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 269:3015-3023, 1993.
    • (1993) JAMA , vol.269 , pp. 3015-3023
    • Stamler, J.1    Wentworth, D.2    Neaton, J.3
  • 118
    • 0029741921 scopus 로고    scopus 로고
    • A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
    • Stampfer M.J., Krauss R.M., Ma J.et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 276:1996;882-888.
    • (1996) JAMA , vol.276 , pp. 882-888
    • Stampfer, M.J.1    Krauss, R.M.2    Ma, J.3
  • 119
    • 0028348823 scopus 로고
    • Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low-density lipoprotein cholesterol
    • Stewart B.F., Brown B.G., Zhae X.-Q.et al. Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low-density lipoprotein cholesterol. J Am Coll Cardiol. 23:1994;899-906.
    • (1994) J Am Coll Cardiol , vol.23 , pp. 899-906
    • Stewart, B.F.1    Brown, B.G.2    Zhae, X.-Q.3
  • 121
    • 0012615809 scopus 로고    scopus 로고
    • Prostaglandin analogues: Their usage and benefits in glaucoma treatment
    • Stewart W.C. Prostaglandin analogues. their usage and benefits in glaucoma treatment Ophthalmic Pract. 14:1996;48-55.
    • (1996) Ophthalmic Pract , vol.14 , pp. 48-55
    • Stewart, W.C.1
  • 122
    • 0027179580 scopus 로고
    • Association of lipoprotein subclass distribution with use of selective and non-selective beta-blocker medications in patients with coronary heart disease
    • Superko H.R., Haskell W.L., Krauss R.M. Association of lipoprotein subclass distribution with use of selective and non-selective beta-blocker medications in patients with coronary heart disease. Atherosclerosis. 101:1993;1-8.
    • (1993) Atherosclerosis , vol.101 , pp. 1-8
    • Superko, H.R.1    Haskell, W.L.2    Krauss, R.M.3
  • 123
    • 0024996141 scopus 로고
    • Plasma high density lipoproteins. Metabolism and relationship to atherogenesis
    • Tall A.R. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest. 86:1990;379-384.
    • (1990) J Clin Invest , vol.86 , pp. 379-384
    • Tall, A.R.1
  • 124
    • 0027942931 scopus 로고
    • The triglyceride issue revisited. Findings from the Helsinki Heart Study
    • Tenkanen L., Pietila K., Mannienen V., Manttari M. The triglyceride issue revisited. Findings from the Helsinki Heart Study. Arch Intern Med. 154:1994;2714-2720.
    • (1994) Arch Intern Med , vol.154 , pp. 2714-2720
    • Tenkanen, L.1    Pietila, K.2    Mannienen, V.3    Manttari, M.4
  • 125
    • 0029103672 scopus 로고
    • Familial hypercholesterolemia regression study. A randomized trial of low-density lipoprotein apheresis
    • Thompson G.R., Maher V.M.G., Mathews S.et al. Familial hypercholesterolemia regression study. A randomized trial of low-density lipoprotein apheresis. Lancet. 345:1995;811-816.
    • (1995) Lancet , vol.345 , pp. 811-816
    • Thompson, G.R.1    Maher, V.M.G.2    Mathews, S.3
  • 126
    • 0020624054 scopus 로고
    • Conflicting clinical trials and the uncertainty of treating mild hypertension
    • Toth P.J., Horwitz R.I. Conflicting clinical trials and the uncertainty of treating mild hypertension. Am J Med. 75:1983;482-488.
    • (1983) Am J Med , vol.75 , pp. 482-488
    • Toth, P.J.1    Horwitz, R.I.2
  • 127
    • 0028910272 scopus 로고
    • Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
    • Treasure C.B., Klein J.L., Weintraub W.S.et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 332:1995;481-487.
    • (1995) N Engl J Med , vol.332 , pp. 481-487
    • Treasure, C.B.1    Klein, J.L.2    Weintraub, W.S.3
  • 128
    • 84942480790 scopus 로고
    • L(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men
    • Valentine J.R., Grayburn P.A., Vega G.L., Grundy S.M. L(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men. Arch Intern Med. 154:1994;801-806.
    • (1994) Arch Intern Med , vol.154 , pp. 801-806
    • Valentine, J.R.1    Grayburn, P.A.2    Vega, G.L.3    Grundy, S.M.4
  • 129
    • 0020534844 scopus 로고
    • The relevance of intrinsic sympathomimetic activity for β-blocker-induced changes in plasma lipids
    • van Brummelen P. The relevance of intrinsic sympathomimetic activity for β-blocker-induced changes in plasma lipids. J Cardiovasc Pharmacol. 5:1983;S51-S55.
    • (1983) J Cardiovasc Pharmacol , vol.5
    • Van Brummelen, P.1
  • 130
    • 0000306390 scopus 로고    scopus 로고
    • Statins do more than just lower cholesterol
    • Vaughan C.J., Murphy M.B., Buckley B.M. Statins do more than just lower cholesterol. Lancet. 348:1996;1079-1082.
    • (1996) Lancet , vol.348 , pp. 1079-1082
    • Vaughan, C.J.1    Murphy, M.B.2    Buckley, B.M.3
  • 131
    • 0029060065 scopus 로고
    • Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the Seven Country Study
    • Verschuren W.M.M., Jacobs D.R., Bloemberg B.P.M.et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the Seven Country Study. JAMA. 274:1995;131-136.
    • (1995) JAMA , vol.274 , pp. 131-136
    • Verschuren, W.M.M.1    Jacobs, D.R.2    Bloemberg, B.P.M.3
  • 132
    • 2642659615 scopus 로고
    • Effects of antihypertensive therapy on serum lipoproteins
    • Weidmann P, Gerber A, Mordasini R: Effects of antihypertensive therapy on serum lipoproteins. Hypertension 5:III120-131, 1983.
    • (1983) Hypertension , vol.5
    • Weidmann, P.1    Gerber, A.2    Mordasini, R.3
  • 133
    • 0025080789 scopus 로고
    • Topical timolol and serum lipoproteins
    • West J., Longstaff S. Topical timolol and serum lipoproteins. Br J Ophthalmol. 74:1990;663-664.
    • (1990) Br J Ophthalmol , vol.74 , pp. 663-664
    • West, J.1    Longstaff, S.2
  • 134
    • 0027449252 scopus 로고
    • Documented need for more effective diagnosis and treatment of familial hypercholesterolemia according to data from 502 heterozygotes in Utah
    • Williams R.R., Schumacher C., Barlow G.K.et al. Documented need for more effective diagnosis and treatment of familial hypercholesterolemia according to data from 502 heterozygotes in Utah. Am J Cardiol. 72:1993;18D-24D.
    • (1993) Am J Cardiol , vol.72
    • Williams, R.R.1    Schumacher, C.2    Barlow, G.K.3
  • 135
    • 0029300214 scopus 로고
    • Pharmacologic therapy of angina pectoris
    • Zavecz J.H., Bueno O. Pharmacologic therapy of angina pectoris. J La State Med Soc. 147:1995;208-216.
    • (1995) J la State Med Soc , vol.147 , pp. 208-216
    • Zavecz, J.H.1    Bueno, O.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.